| scholarly article | Q13442814 |
| P2093 | author name string | Yong Liu | |
| Hua Liu | |||
| Jinbing Zhao | |||
| Hongyi Liu | |||
| Shengxue He | |||
| P2860 | cites work | Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals | Q57832125 |
| Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale | Q70389805 | ||
| Nerve growth factor-mediated expression of galectin-3 in mouse dorsal root ganglion neurons | Q73156859 | ||
| Monocyte chemoattractant protein-1 predicts outcome and vasospasm following aneurysmal subarachnoid hemorrhage | Q81560046 | ||
| The prognostic value of plasma thrombospondin-1 concentrations after aneurysmal subarachnoid hemorrhage | Q85570081 | ||
| Serial galectin-3 for the monitoring of optimally treated stable chronic heart failure: A pilot study | Q87155350 | ||
| Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends | Q24669798 | ||
| Galectin-3 as a regulator of the epithelial junction: Implications to wound repair and cancer | Q26785535 | ||
| Early brain injury, an evolving frontier in subarachnoid hemorrhage research | Q26823982 | ||
| Galectins: structure, function and therapeutic potential | Q28283659 | ||
| Role of galectin-3 as a receptor for advanced glycosylation end products. | Q34039711 | ||
| Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited | Q34090458 | ||
| Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning | Q34285218 | ||
| Galectin-3: an open-ended story | Q34494555 | ||
| Plasma levels of galectin-3-binding protein reflect type I interferon activity and are increased in patients with systemic lupus erythematosus | Q34583337 | ||
| Inflammation, negative nitrogen balance, and outcome after aneurysmal subarachnoid hemorrhage | Q35106607 | ||
| Galectins as inflammatory mediators | Q35646669 | ||
| Galectin-3 in apoptosis, a novel therapeutic target | Q36743604 | ||
| Microglia/macrophage-derived inflammatory mediators galectin-3 and quinolinic acid are elevated in cerebrospinal fluid from newborn infants after birth asphyxia | Q36937939 | ||
| Biomarkers of vasospasm development and outcome in aneurysmal subarachnoid hemorrhage | Q38210503 | ||
| Functions of galectin-3 and its role in fibrotic diseases | Q38246458 | ||
| Prognostic value of serum galectin-3 in patients with heart failure: a meta-analysis | Q38314021 | ||
| Galectin-3 in autoimmunity and autoimmune diseases | Q38542678 | ||
| Role of galectin-3 in the pathogenesis of bladder transitional cell carcinoma | Q38597470 | ||
| High Plasma Levels of Galectin-3 Are Associated with Increased Risk for Stroke after Carotid Endarterectomy | Q38915953 | ||
| Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition? | Q39880670 | ||
| Serum C-reactive protein levels predict neurological outcome after aneurysmal subarachnoid hemorrhage | Q40024929 | ||
| Galectin-3 is upregulated in activated glia during Junin virus-induced murine encephalitis. | Q40317519 | ||
| Loss of Consciousness at Onset of Subarachnoid Hemorrhage as an Important Marker of Early Brain Injury. | Q40329103 | ||
| The change of plasma galectin-3 concentrations after traumatic brain injury | Q40871019 | ||
| Elevation of serum CXC chemokine ligand-12 levels predicts poor outcome after aneurysmal subarachnoid hemorrhage | Q40871345 | ||
| Galectin-3 promotes neural cell adhesion and neurite growth | Q40990002 | ||
| Galectin-3 gene (LGALS3) expression in experimental atherosclerosis and cultured smooth muscle cells. | Q41020090 | ||
| Galectin-3 contributes to neonatal hypoxic-ischemic brain injury | Q43201355 | ||
| Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis | Q44361867 | ||
| Serum galectin-3 level in systemic sclerosis | Q47866004 | ||
| A New Panel of Blood Biomarkers for the Diagnosis of Mild Traumatic Brain Injury/Concussion in Adults | Q48270426 | ||
| Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury. | Q48427366 | ||
| Brain injury visible on early MRI after subarachnoid hemorrhage might predict neurological impairment and functional outcome | Q48665847 | ||
| Toll-like receptor 4 (TLR4) is correlated with delayed cerebral ischemia (DCI) and poor prognosis in aneurysmal subarachnoid hemorrhage | Q49145484 | ||
| Signaling Pathway in Early Brain Injury after Subarachnoid Hemorrhage: News Update. | Q51291264 | ||
| P433 | issue | 10 | |
| P304 | page(s) | e00543 | |
| P577 | publication date | 2016-08-02 | |
| P1433 | published in | Brain and Behavior | Q20708466 |
| P1476 | title | Prognostic value of plasma galectin-3 levels after aneurysmal subarachnoid hemorrhage | |
| P478 | volume | 6 |
| Q40057919 | Galectin-3 and risk of ischemic stroke in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort. |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q47329197 | Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy (Review). |
| Q47733264 | Galectin-3: an emerging biomarker in stroke and cerebrovascular diseases |
| Q47661952 | Increased Plasma Galectin-3 Preceding the Development of Delayed Cerebral Infarction and Eventual Poor Outcome in Non-Severe Aneurysmal Subarachnoid Hemorrhage |
| Q89566827 | Mechanisms of neuroinflammation and inflammatory mediators involved in brain injury following subarachnoid hemorrhage |
| Q50133781 | Possible Role of Inflammation and Galectin-3 in Brain Injury after Subarachnoid Hemorrhage |
| Q90245610 | Role of Damage Associated Molecular Pattern Molecules (DAMPs) in Aneurysmal Subarachnoid Hemorrhage (aSAH) |
| Q41449179 | Serum galectin-3 levels and delirium among postpartum intensive care unit women. |
Search more.